Provider
Interleukin-31 (IL-31) Inhibitor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Quantity Limit
Program effective Date: Jun 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025